This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


Talking With Patients Who Have Major Depressive Disorder About the Benefits and Risks Associated With Atypical Antipsychotics

Roueen Rafeyan, MD, DFAPA, FASAM; George I. Papakostas, MD; W. Clay Jackson, MD, DipTh; and Madhukar H. Trivedi, MD

Published: April 6, 2021

Learn how to talk with patients who have major depressive disorder about antipsychotic treatment in a way that is clear and balanced and addresses patients’ potential concerns about taking antipsychotic medication.

Read the eReport

Quick Links: